Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11400-11405
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11400
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11400
Table 1 Definitions for grades representing the measures of improvement for the urine excretion volume, ascites and edema
| Measure of improvement | |||
| Significant improvement | Improvement | No improvement | |
| Grade | A | B | C |
| Volume of urine excretion | Increased by > 1000 mL/24 h | Increased by 500-1000 mL/24 h | Increased by < 500 mL/24 h |
| Abdominal circumference | Decreased by > 2 cm | Decreased by 0-2 cm | No change |
| Edema (lower extremities) | A lack of visible pitting | Presence of visible pitting | Distinctly visible pitting |
- Citation: Zhang X, Wang SZ, Zheng JF, Zhao WM, Li P, Fan CL, Li B, Dong PL, Li L, Ding HG. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients. World J Gastroenterol 2014; 20(32): 11400-11405
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11400.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11400